Current Status and Prospects of Fertility Preservation Strategies for Patients with Tumors
10.3971/j.issn.1000-8578.2024.24.0636
- VernacularTitle:肿瘤患者生育力保护策略的现状与展望
- Author:
Changyue YAO
1
,
2
;
Hongyun GONG
3
;
Weixi GAO
4
;
Huali LIU
3
Author Information
1. Cancer Center, Renmin Hospital of Wuhan University, Wuhan 430060, China
2. College of Basic Medicine of China Three Gorges University, Yichang 443002, China.
3. Cancer Center, Renmin Hospital of Wuhan University, Wuhan 430060, China.
4. Department of Pharmacy, Renmin Hospital of Wuhan University, Wuhan 430060, China.
- Publication Type:REVIEWS
- Keywords:
Fertility protection;
Radiotherapy;
Chemotherapy;
Targeted therapy;
Immune checkpoint inhibitor
- From:
Cancer Research on Prevention and Treatment
2024;51(12):1040-1045
- CountryChina
- Language:Chinese
-
Abstract:
With the changing disease spectrum, the incidence of tumors is increasing and tends to occur among the youth. The long-term survival rate of patients with cancer has increased significantly, and attention to their reproductive rights is growing. Surgery, chemotherapy, radiotherapy, immunotherapy, and molecular targeted therapy are the conventional treatment methods for cancer, with each exerting different effects on the fertility of patients. Common fertility preservation techniques currently include sperm cryopreservation, embryo and oocyte cryopreservation, ovarian tissue cryopreservation, uterine transplantation, and assisted reproductive technology. This article systematically summarizes the influence of different antitumor treatments on fertility, as well as the current status and prospects of fertility preservation in patients with cancer. This study aims to improve cooperation between clinical oncologists and reproductive medicine doctors to enhance fertility preservation for patients with cancer.
